A Novel Inhibitor of Gyrase B Is a Potent Drug Candidate for Treatment of Tuberculosis and Nontuberculosis Mycobacterial Infections
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Novel Inhibitor of Gyrase B Is a Potent Drug Candidate for Treatment of Tuberculosis and Nontuberculosis Mycobacterial Infections
Authors
Keywords
-
Journal
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Volume 59, Issue 3, Pages 1455-1465
Publisher
American Society for Microbiology
Online
2014-12-23
DOI
10.1128/aac.04347-14
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Optimization of Pyrrolamides as Mycobacterial GyrB ATPase Inhibitors: Structure-Activity Relationship andIn VivoEfficacy in a Mouse Model of Tuberculosis
- (2014) Shahul Hameed P et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroActivity of AZD5847 against Geographically Diverse Clinical Isolates of Mycobacterium tuberculosis
- (2014) Jim Werngren et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Gyrase ATPase Domain as an Antitubercular Drug Discovery Platform: Structure-Based Design and Lead Optimization of Nitrothiazolyl Carboxamide Analogues
- (2014) Variam Ullas Jeankumar et al. ChemMedChem
- Second-Generation Antibacterial Benzimidazole Ureas: Discovery of a Preclinical Candidate with Reduced Metabolic Liability
- (2014) Anne-Laure Grillot et al. JOURNAL OF MEDICINAL CHEMISTRY
- Mycobactericidal Activity of Sutezolid (PNU-100480) in Sputum (EBA) and Blood (WBA) of Patients with Pulmonary Tuberculosis
- (2014) Robert S. Wallis et al. PLoS One
- Bactericidal Activity and Mechanism of Action of AZD5847, a Novel Oxazolidinone for Treatment of Tuberculosis
- (2013) V. Balasubramanian et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Thiazolopyridone ureas as DNA gyrase B inhibitors: Optimization of antitubercular activity and efficacy
- (2013) Ramesh R. Kale et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Thiazolopyridine Ureas as Novel Antitubercular Agents Acting through Inhibition of DNA Gyrase B
- (2013) Manoj G. Kale et al. JOURNAL OF MEDICINAL CHEMISTRY
- Fragment-to-Hit-to-Lead Discovery of a Novel Pyridylurea Scaffold of ATP Competitive Dual Targeting Type II Topoisomerase Inhibiting Antibacterial Agents
- (2013) Gregory S. Basarab et al. JOURNAL OF MEDICINAL CHEMISTRY
- Tricyclic GyrB/ParE (TriBE) Inhibitors: A New Class of Broad-Spectrum Dual-Targeting Antibacterial Agents
- (2013) Leslie W. Tari et al. PLoS One
- Aminopyrazinamides: Novel and Specific GyrB Inhibitors that Kill Replicating and Nonreplicating Mycobacterium tuberculosis
- (2012) Pravin S. Shirude et al. ACS Chemical Biology
- Pyrrolopyrimidine inhibitors of DNA gyrase B (GyrB) and topoisomerase IV (ParE), Part II: Development of inhibitors with broad spectrum, Gram-negative antibacterial activity
- (2012) Micheal Trzoss et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Short-Course Chemotherapy with TMC207 and Rifapentine in a Murine Model of Latent Tuberculosis Infection
- (2011) Tianyu Zhang et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- The oxazolidinones: past, present, and future
- (2011) Karen Joy Shaw et al. Annals of the New York Academy of Sciences
- Evaluation of gyrase B as a drug target in Mycobacterium tuberculosis
- (2011) S. Chopra et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Fast Standardized Therapeutic-Efficacy Assay for Drug Discovery against Tuberculosis
- (2010) J. Rullas et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Short-Course Therapy with Daily Rifapentine in a Murine Model of Latent Tuberculosis Infection
- (2009) Tianyu Zhang et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Paradoxical Effect of Isoniazid on the Activity of Rifampin-Pyrazinamide Combination in a Mouse Model of Tuberculosis
- (2009) D. Almeida et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Novel Dual-Targeting Benzimidazole Urea Inhibitors of DNA Gyrase and Topoisomerase IV Possessing Potent Antibacterial Activity: Intelligent Design and Evolution through the Judicious Use of Structure-Guided Design and Stucture−Activity Relationships
- (2008) Paul S. Charifson et al. JOURNAL OF MEDICINAL CHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now